OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2023
(3)
2025
(2)
2022
(2)
2024
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Use of Naltrexone for Patients With Stimulant Use Disorder in Malaysia: Protocol for a Retrospective Cohort Study.
Not available
S-EPMC12371278
|
biostudies-literature
Cite
Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial.
Not available
S-EPMC8980926
|
biostudies-literature
Cite
Modeled Carbon Footprint of Change of Sterile Gloves and Instruments for Abdominal Wound Closure.
Not available
S-EPMC12329605
|
biostudies-literature
Cite
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19.
Not available
S-EPMC10219675
|
biostudies-literature
Cite
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry.
Not available
S-EPMC10439444
|
biostudies-literature
Cite
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19.
Not available
S-EPMC10114094
|
biostudies-literature
Cite
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods.
Not available
S-EPMC11252333
|
biostudies-literature
Cite
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19.
Not available
S-EPMC9339000
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets